期刊文献+

高危前列腺增生部分切除23例疗效分析 被引量:1

The analysis the effect of high-risk prostatic hyperplasia partial resection of 23 cases
下载PDF
导出
摘要 目的探讨经尿道前列腺电切术对高危前列腺增生部分切除的临床效果和安全性。方法 23例且均伴有其他系统疾病患者采用电切术部分切除治疗。结果 23例患者手术均成功,排尿功能得到改善。结论前列腺电切术损伤小,安全性高,疗效确切,并发症少,适用于高危患者的治疗。 Objective To explore the efficacy and safety of prostatic urethra vaporization electricity cut method(TUVP) treating with high-risk prostate hyperplasia disease.Methods 23 cases suffered with other system disease patients using TUVP treatment.Results All patients were perforaned successfully,and the mictufition function were improved.Conclusion TUVP has 1ittle injury,high safety,efficacy precise,and fewer complications,suitable for high-risk patients treatment.
作者 史柏强
机构地区 宜兴市中医医院
出处 《中外医学研究》 2011年第23期22-23,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 前列腺增生症 经尿道前列腺汽化电切术 高危患者 Prostatic hyperplasia TUVP High-risk patients
  • 相关文献

参考文献5

二级参考文献16

  • 1王建业 邵鸿勋.TURP术中出血量的测定[J].中华泌尿外科杂志,1990,11:146-147.
  • 2Carlin BI, Boder DR, Spirnak JP, et al. Role of finasteride in the treatment of recurrent heamaturia secondary to benign prostatic hyperplasia. Prostate, 1997,31 : 180-182.
  • 3Foley SJ,Soloman LZ, Wedderburn AW .et al. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Uro1,2000,163:436-438.
  • 4Vemeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumors:an international consensus on the methodology and criteria of evaluation. Eur J Cancer, 1996,32A : 2474-2484.
  • 5Hahn RG. Dextran 70 and blood loss during transurethral resection of the prostate. Acta Anaes Scand, 1996,40 ;820-823.
  • 6Lekas JM, Widmark BA, Damber JE. Decrement of blood flow preceeds the involution of the ventral prostate in the rat after castration.Urol Res, 1997,25:309-314.
  • 7Takeshita S, Lu Hang, Brogi E, et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest, 1994,93:662-665.
  • 8Leung D, Cachianes G, Kuarg W, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 1989,246: 1306-1301.
  • 9Yamamoto S,Konishi I, Tsuruta Y, et al. Expression of vascular endothelial growth factor (VEGF) during folliculegenesis and corpus luteum formation in the human ovary. Gynecol Endocrinol, 1997,11 :371-381.
  • 10Haggstrom S,Wikstrom P, Bergh A, et al. Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration.Prostate, 1998,36:71-79.

共引文献253

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部